Quarterly report pursuant to Section 13 or 15(d)

LIQUIDITY (Details)

v3.21.1
LIQUIDITY (Details) - USD ($)
$ in Thousands, shares in Millions
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Apr. 14, 2021
Oct. 09, 2020
Apr. 30, 2021
Mar. 31, 2021
Mar. 31, 2020
Mar. 31, 2021
Mar. 31, 2020
Jun. 30, 2020
Jun. 30, 2019
Net loss       $ (3,695) $ (5,040) $ (14,412) $ (16,786) $ 20,300  
Net cash used in operating activities           (15,211) (20,090) 24,200  
Accumulated deficit       (161,648)   (161,648)   (147,236)  
Cash, cash equivalents and restricted cash       31,989 14,033 31,989 14,033 9,955 $ 11,573
Total liabilities       3,801   3,801   3,600  
Gross proceeds from private placement of equity shares   $ 41,000              
Number of shares issued   2.5              
Warrants for the purchase of shares of Common Stock   $ 800              
Restricted Cash         0   0    
Existing cash and cash equivalents balance       $ 31,989 $ 14,033 $ 31,989 $ 14,033 $ 9,955  
Subsequent events                  
Debt financing proceeds     $ 15,000            
Loan and security agreement                  
Variable margin rate 0.12%                
Loan and security agreement | Subsequent events                  
Maximum borrowing capacity $ 30,000   30,000            
Debt financing proceeds     15,000            
Remaining borrowing capacity     15,000            
Restricted Cash     $ 5,000            
Stated interest rate 8.75%   8.75%            
Variable margin rate 0.12%   0.12%